Alan Bryce presenting first results of the positive TRITON3 study of rucaparib in refractory mCRPC!

Great work from Joanina Gicobi, Ph.D. (She/Her) et al on the metabolic features of resilient CD8-T cells. Malic enzyme 1 (ME1) is a critical factor for ROS homeostasis and cytotoxic function #Immunometabolism #cd8tcells

Mayo Clinic joins the Union for International Cancer Control and other global organizations on #WorldCancerDay, Feb. 4, to close the gap and reduce inequities in cancer care. Here are five ways to help reduce your risk of cancer: mayocl.in/3XTQjF7 Mayo Clinic Comprehensive Cancer Center

A Mayo Clinic Urology paper just published Cell Reports Medicine found a new therapeutic vulnerability of lethal prostate cancer. Dr. Veronica Rodriguez-Bravo team uncovered how a tumor’s high chromosomal instability (CIN) can be turned against itself. bit.ly/3XSKvLh #ProstateCancer #Urology

I had the privilege of a student shadowing me today I think his main takeaway (other than my obvious caffeine addiction) was that oncology looks VERY different outside the hospital If any trainee is considering cancer care please rotate through clinic! ascopubs.org/doi/10.1200/JO…

New #ETCTN #prostatecancer #clinicaltrial activation: (10603), “Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer’, led by Jake Orme MD PhD of Mayo Clinic Comprehensive Cancer Center. buff.ly/3rUxMxg #NCICTEP

Biblically correct ophthalmologist?

Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation | Science Advances science.org/doi/full/10.11…

The clinical trials process has become so convoluted! Walter Stadler succinctly breaks down a $100B industry in 7 minutes, challenging us to stop doing stupid stuff. ✅Ask simple questions ✅Ask only what needs to be done, question "but X requires this" ✅KISS #DAVABroadmoorGU

Thank you, UroToday.com for highlighting our work and for all you do to shed light on the fight against prostate cancer! Emmanuel Antonarakis Mayo Clinic Comprehensive Cancer Center urotoday.com/video-lectures…

Fond memories of a chilly December evening... Thanks so much IJROBP - The Red Journal for allowing me to share this special event.

FINALLY - what I have been looking forward to prove for 20 years: the detection performance of DRE for PCa is so weak that we can forego this exam. Hope the guidelines take this evidence to stop recommending DRE for PCa screening/early detection. sciencedirect.com/science/articl…

Mayo Clinic Hematology-Oncology Fellowship Saurabh Zanwar One of the best physicians, scientists, and a dear friend. Congratulations!!!

Today ASCO #GU24 don't miss Fabrice Lucien, PhD Poster #H20, 11:30 PST Prognostic value of PSMA-extracellular vesicles in oligometastatic castration-sensitive prostate cancer treated with stereotactic ablative radiotherapy: A multi-center observational study. #ProstateCancer Ali Arafa

Happy to see online Nature Reviews Urology our forward thinking review on chromosomal instability (CIN) in #prostatecancer it was fun to write this piece MayoClinicBMB Mayo Clinic Urology Mayo Clinic Comprehensive Cancer Center rdcu.be/dxIxA

Thank you Front Line Genomics for interviewing me about this work last year (when I was still Wash U Radiation Oncology) — Our paper published npj Journals Precision Oncology with 1st author Nick Semenkovich, MD PhD. Hoping to take this concept forward in a big way Mayo Clinic Radiation Oncology (where I am currently) Kenneth Olivier

Research Fellowship position available in our lab. At the intersection of cancer cell biology and immunology to dissect mechanisms of immune evasion and therapeutic resistance and develop novel therapies Mayo Clinic Urology …wp-saasfaprod1.fa.ocs.oraclecloud.com/hcmUI/Candidat…